Patient presents with abnormal uterine bleeding, a common symptom of proliferative endometrium.  This includes heavy menstrual bleeding (menorrhagia), prolonged periods, or bleeding between periods (metrorrhagia).  The patient's age and menopausal status are relevant factors for endometrial hyperplasia risk assessment.  Pelvic examination findings are documented.  Transvaginal ultrasound was performed, revealing an endometrial thickness of  (insert measurement) mm, suggestive of endometrial thickening and possible proliferative endometrium.  Differential diagnoses include endometrial polyp, endometrial hyperplasia, and endometrial carcinoma.  Endometrial biopsy or dilation and curettage (D C) is recommended for histopathological evaluation to confirm the diagnosis and rule out malignancy.  Based on the pathology results, a treatment plan will be formulated, which may include hormonal therapy, such as progestins, or hysterectomy in cases of atypical hyperplasia.  Patient education regarding the risks and benefits of each treatment option will be provided.  Follow-up appointments are scheduled for monitoring endometrial thickness and response to therapy.  ICD-10 code N85.0 for proliferative endometrium is considered, pending definitive diagnosis.  Medical coding and billing for the procedures and consultations will be performed according to established guidelines.